Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”
2026.05.01
CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China
2026.05.01
EBMT Global Perspective | Professor Donal McLornan: Defining Remission Criteria and Optimizing Novel Combination Strategies for Bone Marrow Transplantation in MDS/MPN Overlap Syndromes
2026.05.01
EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies
2026.04.30
EBMT Global Perspective | Professor Francesca Ferrua: Breakthroughs in Autologous Hematopoietic Stem Cell Gene Therapy for WAS—From Concept to Clinical Practice
2026.04.30
EBMT Global Perspective | Professor Annalisa Ruggeri: Cord Blood Transplantation—From Established Platform to Frontier Therapeutic Modality
2026.04.30
Professor Yuankai Shi: Thirty-Five Years of Iterative Innovation—Lymphoma Leading China’s Modernization in Oncology Drug Therapy | 2026 CACA Western Integrative Oncology Conference
2026.04.30
Annual Meeting of the Hematology Branch, CPAM | Professor Yajing Xu: Long-Term Follow-Up Management After Hematopoietic Stem Cell Transplantation—From Digital Solutions to Primary Care Collaboration
2026.04.30
AACR China Voice | Qilu Pharmaceutical Showcases Multiple Innovative Breakthroughs at AACR, Driving Global Advances in Oncology Through Originative Innovation
2026.04.29
AACR China Voice | Professor Tao Zhu: First-in-Human Study of CLDN6 ADC QLS5132 Demonstrates Promising Efficacy and Safety, Opening New Directions for Platinum-Resistant Ovarian Cancer
2026.04.28
Posted inHematology Frontier

CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”

Posted by By Mourabit Halima 2026.05.01
Continue Reading
Posted inHematology Frontier

CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China

Posted by By Peng Longmei 2026.05.01
Continue Reading
Progress and Challenges of Novel Immunotherapy Targets

Progress and Challenges of Novel Immunotherapy Targets

Posted by By Mourabit Halima 2025.07.01
Read More
Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer

Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer

Posted by By Mourabit Halima 2025.07.01
Read More
New Practices in Precision Tumor Immunotherapy

New Practices in Precision Tumor Immunotherapy

Posted by By El Bachir MOURABIT 2025.07.01
Read More
HER2-targeted Efficacy Prediction Model Based on Gastric Cancer Microenvironment Characteristics

HER2-targeted Efficacy Prediction Model Based on Gastric Cancer Microenvironment Characteristics

Posted by By Lisa Cui 2025.07.01
Read More
Progress in Clinical New Drugs and Translational Research on FGFR-Altered Gastric Cancer

Progress in Clinical New Drugs and Translational Research on FGFR-Altered Gastric Cancer

Posted by By Mourabit Halima 2025.07.01
Read More
Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer

Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer

Posted by By Lisa Cui 2025.07.01
Read More
Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Posted by By Ren Jiamo 2025.07.01
Read More
Early research, clinical practice and thinking of innovative NK cell therapy

Early research, clinical practice and thinking of innovative NK cell therapy

Posted by By Mourabit Halima 2025.07.01
Read More
Clinical and Translational Research on Gastric Cancer Based on Molecular Typing

Clinical and Translational Research on Gastric Cancer Based on Molecular Typing

Posted by By Peng Longmei 2025.07.01
Read More
Research Progress of Artificial Intelligence in the Field of Digestive System Tumors

Research Progress of Artificial Intelligence in the Field of Digestive System Tumors

Posted by By Mourabit Halima 2025.07.01
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”
  • CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China
  • EBMT Global Perspective | Professor Donal McLornan: Defining Remission Criteria and Optimizing Novel Combination Strategies for Bone Marrow Transplantation in MDS/MPN Overlap Syndromes
  • EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies
  • EBMT Global Perspective | Professor Francesca Ferrua: Breakthroughs in Autologous Hematopoietic Stem Cell Gene Therapy for WAS—From Concept to Clinical Practice
Recent Comments
    Archives
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inHematology Frontier
    CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”
    Posted by By Mourabit Halima 2026.05.01
    Posted inHematology Frontier
    CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China
    Posted by By Peng Longmei 2026.05.01
    Posted inHematology Frontier
    EBMT Global Perspective | Professor Donal McLornan: Defining Remission Criteria and Optimizing Novel Combination Strategies for Bone Marrow Transplantation in MDS/MPN Overlap Syndromes
    Posted by By Mourabit Halima 2026.05.01
    Posted inHematology Frontier
    EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies
    Posted by By Mourabit Halima 2026.04.30
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied